Peter Rahmer insider trades: Relay Therapeutics (RLAY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | RLAY | ↓ Sell | 753 | $18.62 | $14K | Direct | Oct 30, 2026 (2d) |
| Aug 26, 2026 | RLAY | ↓ Sell | 4,508 | $20.03 | $90K | Direct | Aug 28, 2026 (2d) |
| Jul 28, 2026 | RLAY | ↓ Sell | 748 | $18.61 | $14K | Direct | Jul 30, 2026 (2d) |
| Apr 28, 2026 | RLAY | ↓ Sell | 753 | $14.79 | $11K | Direct | Apr 30, 2026 (2d) |
| Jan 28, 2026 | RLAY | ↓ Sell | 13,038 | $7.71 | $100K | Direct | Jan 29, 2026 (1d) |
| Oct 29, 2025 | RLAY | ↓ Sell | 40,529 | $7.40 | $300K | Direct | Oct 30, 2025 (1d) |
| Jul 29, 2025 | RLAY | ↓ Sell | 17,083 | $3.68 | $63K | Direct | Jul 30, 2025 (1d) |
| Apr 30, 2025 | RLAY | ↓ Sell | 12,103 | $3.02 | $37K | Direct | Apr 30, 2025 (0d) |
| Mar 27, 2025 | RLAY | ↓ Sell | 247 | $2.84 | $701 | Direct | Mar 31, 2025 (4d) |
| Jan 30, 2025 | RLAY | ↓ Sell | 45,464 | $4.50 | $205K | Direct | Jan 30, 2025 (0d) |
| Jan 6, 2025 | RLAY | ↓ Sell | 80,909 | $4.27 | $346K | Direct | Jan 6, 2025 (0d) |
| Dec 27, 2024 | RLAY | ↓ Sell | 400 | $4.38 | $2K | Direct | Dec 31, 2024 (4d) |
| Oct 28, 2024 | RLAY | ↓ Sell | 1,621 | $6.06 | $10K | Direct | Oct 30, 2024 (2d) |
| Sep 27, 2024 | RLAY | ↓ Sell | 245 | $7.51 | $2K | Direct | Oct 1, 2024 (4d) |
| Jul 31, 2024 | RLAY | ↓ Sell | 42,359 | $8.34 | $353K | Direct | Jul 31, 2024 (0d) |
| Jun 27, 2024 | RLAY | ↓ Sell | 245 | $6.26 | $2K | Direct | Jul 1, 2024 (4d) |
| Jun 5, 2024 | RLAY | ↓ Sell | 80,909 | $6.70 | $542K | Direct | Jun 5, 2024 (0d) |
| Apr 29, 2024 | RLAY | ↓ Sell | 1,345 | $6.38 | $9K | Direct | Apr 29, 2024 (0d) |
| Mar 27, 2024 | RLAY | ↓ Sell | 298 | $7.70 | $2K | Direct | Mar 29, 2024 (2d) |
| Jan 29, 2024 | RLAY | ↓ Sell | 1,651 | $9.64 | $16K | Direct | Jan 31, 2024 (2d) |
| Dec 27, 2023 | RLAY | ↓ Sell | 244 | $11.51 | $3K | Direct | Dec 29, 2023 (2d) |
| Oct 30, 2023 | RLAY | ↓ Sell | 1,354 | $6.03 | $8K | Direct | Nov 1, 2023 (2d) |
| Sep 27, 2023 | RLAY | ↓ Sell | 244 | $8.38 | $2K | Direct | Sep 29, 2023 (2d) |
| Jul 28, 2023 | RLAY | ↓ Sell | 1,352 | $11.80 | $16K | Direct | Jul 31, 2023 (3d) |
| Jun 27, 2023 | RLAY | ↓ Sell | 244 | $12.12 | $3K | Direct | Jun 28, 2023 (1d) |
| Apr 28, 2023 | RLAY | ↓ Sell | 739 | $11.16 | $8K | Direct | May 1, 2023 (3d) |
| Mar 27, 2023 | RLAY | ↓ Sell | 297 | $15.36 | $5K | Direct | Mar 28, 2023 (1d) |
| Jan 30, 2023 | RLAY | ↓ Sell | 740 | $21.56 | $16K | Direct | Jan 31, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RLAY insiders
Open-market trades in the last 12 months
About Peter Rahmer's insider trades
Peter Rahmer is See remarks at Relay Therapeutics (RLAY). Since Jan 30, 2023, Peter has reported no open-market purchases and 28 sales worth $2.2M on SEC Form 4. In the last 12 months: 5 sales ($230K).
Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.